Delivery Order SPE2DB20D2014-SPE2DB24FB21C
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,048.20, is a Delivery Order for the supply of CLINDAMYCIN 600 MG/50 ML-D5W 50ML, a pharmaceutical product, with a performance period through December 31, 2024. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,398.72 firm fixed price contract is for the supply of 4565357729 ! CLINDAMYCIN 600 MG/50 ML-D5W 50ML, with a completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to...
- This federal contract award, valued at $6,580.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of 4565915672 - CLINDAMYCIN 900 MG/50 ML-NS 50ML, a pharmaceutical product. The contract has an ultimate completion date of September 25, 2024 and is a firm fixed-price, non-set-aside contract. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical and medical products to various...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,278.92 fixed-price delivery order is for the supply of Clindamycin PH 1% Solution (60 ml), with a completion date of March 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,250.04 firm fixed price delivery order is for the supply of 4563412457 - CLINDAMYCIN 900 MG/50 ML-D5W 50ML, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,632.26 firm fixed-price contract is for the delivery of Clindamycin PH 900 mg/6 ml vials. The award is not set-aside and has an ultimate completion date of June 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,684.59, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565158696 - CLINDAMYCIN 60ML 1S, a pharmaceutical product. The contract has a completion date of July 17, 2024 and is a Firm Fixed Price Delivery Order. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a delivery order valued at $1,337.04 for the supply of the pharmaceutical product Clindamycin 60ML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of August 14, 2024. The contract is not set aside and is a firm fixed-price agreement. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor with...
- This federal contract award, with identification number SPE2DB20D3101|SPE2DB25FQYW5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,277.72 firm fixed-price delivery order is for the supply of 4566915822 CLINDAMYCIN 900 MG/50 ML-NS 50ML, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,539.05 firm fixed-price delivery order is for the supply of 600 mg/50 mL clindamycin antibiotic solution in 50 mL bags. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities to...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB21CDelivery Order
This federal contract award, valued at $6,064.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of CLINDAMYCIN 900 MG/50 ML-D5W 50ML, a generic pharmaceutical product. The contract has an Ultimate Completion Date of March 5, 2024 and uses a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award did not utilize any set-aside designation, indicating open competition. No subcontractors were mentioned in the provided information.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 3/4/24 |